https://www.zonebourse.com/cours/action/2SEVENTY-BIO-INC-128358117/actualite/Regeneron-Pharmaceuticals-Inc-NasdaqGS-REGN-a-finalise-l-acquisition-du-pipeline-de-R-D-de-2sev-46330122/?utm_source=telegram&utm_medium=social&utm_campaign=share